Pharmacy Podcast Network

The new podcast called “Decoder with Nilay Patel” episode 1 @reckless released on Nov 10, 2020 with special guest MARK CUBAN ON AMERICA’S FUTURE & a short clip about Cost Plus Drugs. Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company. Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs.  The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result. Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs. In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs.  Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Special Episode: A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi  Todd Eury here, founder of the Pharmacy Podcast Network, with a first for our listeners since launching in 2009, I interview the most important person in healthcare, our patient. The mother of a little 10 year old girl, Livi, who has brain cancer.  Livi's mother is Shannon Sealy, from my home town, Brownsville Pennsylvania.  Help Livi Beat Brain Cancer CLICK HERE TO DONATE:  https://www.gofundme.com/f/help-livi-beat-brain-cancer?rcid=bae1ad4959be44a795bf8566e381dc7a&utm_campaign=p_na+share-sheet&utm_medium=copy_link&utm_source=customer  Data from this episode:  Corticosteroids in brain cancer patients: benefits and pitfalls  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109638/  Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood:  https://pubmed.ncbi.nlm.nih.gov/8487049/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy. This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today! Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011 CPE details for GameChangers Podcast January 2021 Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting 0107-0000-21-079-H01-P 0.2 CEU/2.0 Hrs (Knowledge) Initial Release Date: 01/25/21 Expiration Date: 01/26/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Garrett Sipes, PharmD of Chambers’ Apothecary in Chambersburg, Pennsylvania. Recently, this pharmacy has successfully implemented COVID-19 testing. Garrett walks us through this process step-by-step and shares valuable lessons learned for pharmacists looking to get involved.  All the PPA Podcasts: https://www.papharmacists.com/page/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's special guest is Susan Garfield, DrPH, Principal | Commercial Lead | Health Sciences and Wellness Sector with Ernst & Young LLP. Susan is an author on the study titled: Reimagined the Life Sciences Beyond COVID-19 Summary:  From payer-mix changes, to pricing and profitability concerns, COVID-19 has made the biopharma industry fraught with market and other pressures. However, these circumstances have also presented new opportunities, including accelerated adoption of digital tools and approaches. This was all made clear when we, in association with EY, surveyed 550+ biopharma executives - from R&D to commercial – to gain practical insights on the current state and long-term outlook for the industry. This new free report ‘Beyond COVID-19: Life sciences reimagined’ highlights key findings from our analysis and is intended to help establish a framework for more patient-focused, sustainable care delivery post-crisis. Download this 30+ page report and: See the impact of COVID-19 across the product lifecycle, highlighting commercial, HCP needs and relationships, marketing and the sales model, patient engagement, medical affairs and R&D – with one of the largest surveys of senior-pharma professionals during the pandemic Hear from pharma leaders who are plotting the industry’s re-mergence strategies into the “new normal” Benchmark your own response and experience to COVID-19 against hundreds of industry peers Download this 30+ page report for free here. Insights from industry leaders, include: Karan Arora, Chief Commercial Digital Officer, AstraZeneca Chetak Buaria, Global Head of Customer Engagement & Channel Evolution, Biopharma Global, Merck Kabir Nath, President, Otsuka North America Pharmaceutical Business Harmony Garges, CMO, ViiV Healthcare  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The unbelievable happened in 2020 - a vaccine was developed with high efficacy within 12 months for a novel virus! In December two vaccines for the prevention of the SARS-CoV-2 virus were approved through Emergency Use Authorization in the US. Is it time to get a shot? This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Polack F, Thomas S, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM. Dec 10, 2020. DOI: 10.1056/NEJM2034577 Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NEJM. Dec 30, 2020. DOI: 10.1056/NEHMoa2035389 ACIP Recommendations: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ina Shah entered Albany College of Pharmacy and Health Sciences through the non-traditional Doctor of Pharmacy degree program.  After successfully balancing the demands of work and school, she graduated in 2001 ready for a career in the industry.  Now she’s the executive director medical information for Abbvie.  Ina credits the ACPHS Pharm D program with preparing her for this essential work by giving her a clinical background, exposing her to a wide variety of therapeutics, and helping her hone her expertise in medical writing.  In this edition of Occupation Station, Ina talks about the challenges in the field, communicating essential information to both consumers and members of the medical community through multiple communications channels.   She also talks about the excitement of being an essential part of Phase 3 and Phase 4 drug trials, where her critical thinking and communication skills are called upon during the regulatory process of applying for an NDA or SNDAs for new products. This episode of the Pharmacy Podcast Network was sponsored by AudioRx.study  AudioRx is the first Uber-Podcasting platform for the Pharmacy Industry.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Quick podcast from Darshan Kulkarni, PharmD, Esq., about hiring the right 5 people to help you build a successful compounding business.  This episode is sponsored by AudioRx.study.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Join hosts Monique Whitney and Scott Newman, with this month's special guests Medicure President, Neil Owens, and Marley Drug founder, Dave Marley. They'll discuss the problems of PBM involvement in the prescription drug supply chain from a drug manufacturer's perspective, and how, by joining forces, PBMs can be removed from the equation.  Learn more at TruthRx.org See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this interview, Dr. Leland shares his perspectives on the APhA practice guidance requirements for pharmacy-based MAS from the context of his experience as a Pharmacy Manager. The Practice Guidance For Pharmacy-Based MAS was developed in 2017 by the APhA, and can be accessed on PsychU here. Rob Leland, PharmD, is the Pharmacy Manager & Owner of First Avenue Pharmacy in Spokane, Washington; the first pharmacist-run long-acting injectable clinic in the State of Washington. He recently served on the advisory board for the American Pharmacists Association (APhA) Pharmacy-Based Medication Administration Services (MAS) Guide. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices